-
Clene's Amyotrophic Lateral Sclerosis Candidate Delays Disease Progression, New Data Shows
Thursday, March 9, 2023 - 10:37am | 384Clene Inc (NASDAQ: CLNN) announced new results from exploratory analyses, including delayed time to key clinical progression events in amyotrophic lateral sclerosis (ALS) patients treated with CNM-Au8 in the HEALEY ALS Platform Trial over the 6-months. ALS is a progressive nervous...
-
Here's The Tweet That Caused Shares Of Brainstorm Cell Therapeutics To Spike
Friday, April 10, 2015 - 12:55pm | 258Shares of small-cap Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI) spiked more than 6 percent Friday morning after prominent neurosurgeon Dr. Sanjay Gupta tweeted there is now a "ray of hope" for millions of people that are suffering from Lou Gehrig's disease. finally, a ray of hope for millions...